chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This genocide this bioweapon; My father and my cousin had died so far; This is a spontaneous report received from a non-contactable reporter (Nurse).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as DOSE NUMBER UNKNOWN, SINGLE (batch/ot number: unknown) for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death, medically significant), outcome "fatal" described as "This genocide this bioweapon; My father and my cousin had died so far." The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed.  Additional information: The reporter (Registered Nurse) stated, "I am not worrying about getting disconnected. Are you involved in this genocide this bioweapon COVID 19 jab (COVID-19 Vaccine)? Do you know it is a withheld violation? You are a pharmacist you know what is going on. Yes, I am a registered nurse and I know what is going on to the violation. I have known for two years why you knew 6 months after Pfizer did, that is what going to happen to Pfizer. Where you located are you in (country)?" Reporter further stated, "I hope you are not involved in this Genocide because you know what they did with other people (not clarified) and knowingly or just say I was doing my job getting proud of it either then people also bring violation. You know about (withheld) do you not? You are educated you are a Pharmacist. What about this fake protein mRNA's that's making people 'creates' by protein? Did you have any family members died yet? My father and my cousin had died so far. Did you have anyone died in (country) or do they ban it in (country)?" Reporter also stated, "Can you have false information? Who would believe Pfizer. You are part of that plan. (withheld) 2.0 study up on that, you know they hung people (further clarifications unknown)." The Reporter hung up the call abruptly. Thus, further probing was not done.   No follow-up attempts are possible; information about the batch/lot number cannot be obtained. No further information is expected.; Sender's Comments: Based on available information and temporal association the causal role of suspect product cannot be excluded for reported events Case will be reviewed on receipt of FU information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate,Linked Report(s) : US-PFIZER INC-202300043076 same reporter/drug/event, different patient;; Reported Cause(s) of Death: This genocide this bioweapon; My father and my cousin had died so far
Patient diagnosed with COVID-19 on 7/19/2021 and hospitalized in special care unit. Started with increasing shortness of breath needing morehome oxygen than his usual. Low grade temp. SO called EMS and brough to local facility where he was diagnosed with COVID. Patient also diagnosed with encephalopathy.  Chest x-ray was negative. Currently being treated with Remdesivir.
This spontaneous report was received from an unspecified reporter referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, drug allergies/reactions or concomitant medications was not provided. On 15-OCT-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, (valid lot number T033814, expiration date: 05-OCT-2022), administered for prophylaxis (strength, vaccination scheme frequency, anatomical location, and route of administration were not provided). The administered dose of the vaccine experienced a temperature excursion of 12.4 degrees Celsius for 53 minutes; 9.6 degrees Celsius for 34 minutes; 9.5 degrees Celsius for 23 minutes; and 8.5 degrees Celsius for 9 minutes. There was no adverse effect reported.; Sender's Comments: US-009507513-2112USA006870: US-009507513-2112USA007442: US-009507513-2112USA007443.
Patient self reported sore arm for 3 weeks.  Administered Daptacel to adult patient. Patient should have received Adacel. Daptacel box and vial not marked for pediatric use at time of administration. Error found when new Daptacel box received and new box was marked pediatric.
Several months after receiving one dose of varicella virus vaccine live the pt developed chickenpox. Two other family members reportedly had similar experiences.
Pt was hospitalized from 3/19-3/21 for intractable n/v following COVID-19 vaccination and subsequently had a type 2 NSTEMI. Pt states she got her vaccine on Thursday and then developed severe GERD sx that night. She states she normally does not have GERD and she tried antacids and PPI for her sx. She states she tried to sleep but awoke with projective vomiting and was unable to stop this. She also had myalgias and fatigue. She went to ER and hospital notes indicate supportive care was given and sx resolved quickly. Pt never developed any CP or SOB.
Headache, tiredness, and nausea.   I would say moderate.  Just treating at home but after two days I still have a pretty bad headache.  I will see someone if it does not subside in a couple of days.
Fever, chills, body aches, headaches, nasal congestion, runny nose, ear pressure.
This spontaneous report as received from a nurse refers to a patient of unknown age. On 04-DEC-2013 the patient was vaccinated with MMR II lot # 1885AA and expiry date 30-NOV-2013. The patient was administered expired vaccine. This is 2 of 2 reports from same reporter. Additional information has been requested.
On October 27, 2022 I started to feel heart flutters, I was diagnosed with Atrial Fibrillation.
At 7 pm arm began hurting, by 11 pm was vomiting then passed out, vomited 4 more times during the night and passed out each time very briefly, for a total of 5 times.  Stopped by 6 a.m.   Did not vomit or pass out any more after 6 a.m.  Next day (1/19/21) stayed in bed and slept most of day, started eating again normally 1/20/21.  Feels much more normal 1/21/20 other than sore arm.
Cold; High cholesterol; Light headed; Sore shoulder; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold), BLOOD CHOLESTEROL INCREASED (High cholesterol), DIZZINESS (Light headed) and ARTHRALGIA (Sore shoulder) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Ankylosing spondylitis.    No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced NASOPHARYNGITIS (Cold), BLOOD CHOLESTEROL INCREASED (High cholesterol), DIZZINESS (Light headed) and ARTHRALGIA (Sore shoulder). At the time of the report, NASOPHARYNGITIS (Cold), DIZZINESS (Light headed) and ARTHRALGIA (Sore shoulder) had resolved and BLOOD CHOLESTEROL INCREASED (High cholesterol) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood cholesterol: High.         Concomitant product use was not provided by the reporter.  It was unknown if patient was enrolled in a COVID-19 vaccine trial.  The reporter's causality with Humira for the events of high cholesterol, sore shoulder, light headed and cold was not provided.  No treatment information was provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   This case was linked to MOD-2022-623266, MOD-2022-623262 (Patient Link).
About 5 days after recieving  my first dose of the Pfizer vaccine. I got out of the shower and noticed a small rash forming on my left inner leg. Since then it has spread about the back on my leg and lower buttocks and down my leg slightly.
Redness, swelling at site of injection in left leg beginning 4 days after vaccination, today had 3 cm induration, 1 cm erythema with white drainage
I am experiencing joint soreness in my knees; This spontaneous case was reported by a patient and describes the occurrence of ARTHRALGIA (I am experiencing joint soreness in my knees) in a patient of an unknown age and gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.  On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (I am experiencing joint soreness in my knees). At the time of the report, ARTHRALGIA (I am experiencing joint soreness in my knees) outcome was unknown.      The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  The patient experienced joint soreness in knees.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 01-Nov-2023: Live follow-up information received included updated reporter details and reference ID's.
This spontaneous case, was received from other-health professional on 03-Oct-2017, concerning a 29-year-old adult female patient. The patient did not have relevant medical history. On 03-Oct-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, batch number: 195124, expiry date: Apr-2018, route of administration: intramuscular, anatomical location: right deltoid). On the same day, at night, the patient developed injection site as red, swollen, hard, painful, hot to touch and complained that it hurts. The patient felt there was no redness at the vaccination site but was lifted. On 09-Oct-2017, the patient was recovered from the events. The reporter assessed the events as non-serious. Follow up report received on 11-Oct-2017: The route of administration (intramuscular), anatomical location (right deltoid) of the vaccine and outcome of the events from not recovered to recovered on 09-Oct-2017 were updated. Non-significant follow up received on 25-Oct-2017 from reporter (nurse): the patient did not have relevant medical history. Significant case correction received with IRD 03-Oct-2017: Listedness of the event injection site swelling was corrected.
patient developed fever severe swelling in left arm spreading up through neck  very painful in her neck and she states she cant turn her head
No additional AE reported; GARDASIL 9 was stored improperly and administered; This spontaneous report as received from a licensed practical nurse refers to a patient of an unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 29-JUL-2020, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot # 1637651, expiration date 09-JUN-2022 (dose, route of administration and anatomical location were not reported) for prophylaxis. Administered dose of vaccine was exposed to temperature of 50 degrees Fahrenheit for 1 hour and 46 minutes. There were no previous excursions reported. Digital data logger was involved. There was no additional adverse effect reported.  This is one of several reports received from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1637651; expirationdate: 09-JUN-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2007USA012014: US-009507513-2007USA012054: US-009507513-2007USA012061: US-009507513-2008USA000266: US-009507513-2007USA012124: US-009507513-2008USA000307: US-009507513-2008USA000314: US-009507513-2008USA000367: US-009507513-2008USA000370: US-009507513-2008USA000372:
1/7- RECEIVED VACCINE AND REPORTED HAVING TINGLING TO LIPS (A FEW HOURS LATER), TOOK BENADRYL AND REPORTED THAT TINGLING WENT AWAY.  1/8- REPORTED TINGLING TO LEFT OUTERLIP AND AND WENT TO ER AND DIAGNOSED WITH BELL PALSY / FACIAL PARALYSIS AFTER EVALUATION
Hospitalization: 9/26/2022 - 10/1/2022.  Presentation to the ED: AMS (Altered mental status) COVID-19 + date: 9/24/2022.  Treatment: NO SPECIFIC TREATMENT FOR COVID-19. Discharge to: Private.
Initial unsolicited report received from a consumer on 29 Sep 2016. This case involves a female patient (age not reported) who was vaccinated with a dose of FLUZONE QIV (Batch number expiration date, route of administration was not reported) on 27 Sep 2016. Illness at time of vaccination, pre-existing physician diagnosed allergies, birth defects, medical conditions included no known allergies were not reported. Concomitant medications were not reported. On unspecified date, following the vaccination, the patient had around site felt hot, itchy, had feeling of sniffles, sore throat, and had feeling like fluid was underneath her skin. Relevant diagnostic tests/laboratory data and corrective treatment were not reported. The outcome of the events were unknown. List of documents held by sender: none.
Information has been received from a patient concerning his wife who on an unspecified date, was vaccinated with a dose of MMR II vaccine. The reporter stated that on an unspecified date, his wife had an adverse reaction to MMR II vaccine 7 to 8 years ago. Additional information has been requested.
From the time the vaccine was administered till the next morning I experienced intense Uterine cramping. I also experienced chest tightness for the first hour after the first dose, chest muscles tightness.
tested positive for covid 19 even though patient has had 3 pfizer vaccines; tested positive for covid 19 even though patient has had 3 pfizer vaccines; This is a spontaneous report received from a contactable reporter (Physician) for a Pfizer sponsored program. The reporter is the patient, a family practice physician.  A 71 year-old patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 3 (booster dose), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "B cell lymphoma" (ongoing), notes: in remission; "Weakened immune system" (ongoing). The patient's concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "tested positive for covid 19 even though patient has had 3 pfizer vaccines". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive. Therapeutic measures were taken as a result of covid-19, drug ineffective.Clinical course: Patient's oncologist was concerned about patient weakened immune system and arranged for patient to get paxlovid thru an infectious disease specialist and patient had stated it today.   The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: A contributory role of BNT162B2 to event tested positive for covid 19 even though patient has had 3 pfizer vaccines cannot be excluded based on temporal association and available information.
sick hours; Initial information was received on 16-Feb-2021 regarding an unsolicited valid serious case from a consumer or other non-professional via media.  This case involves an adult patient (age and gender unspecified) who got sick hours (illness), after receiving INFLUENZAVACCINE.  The patient had received first vaccination of INFLUENZA VACCINE in 1973 as past vaccination after which patient got sick and hospitalized.  The patient had no other medical history, concomitant disease or risk factor. Past medical treatment, family history and concomitant medication were not reported.  On an unknown date, in 1975, the patient received a second dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number, expiry date and other dosing details were not reported] for prophylactic vaccination.  On an unknown date, the patient got sick hours (illness) (unknown latency) following the administration of INFLUENZA VACCINE. The patient was hospitalized for this event.  It was unknown if the patient experienced any additional symptoms/events.  There were no laboratory data/results available.   It was not reported if the patient received any corrective treatment.  At the time of reporting, event outcome was reported as unknown for illness.   There will be no information available on the batch number for this case.; Sender's Comments: This was a poorly documented social media case involving an adult patient (age and gender unspecified) who experienced illness, after vaccination with INFLUENZAVACCINE. The time to onset is unknown with the role of the vaccine. With previous first vaccination with same vaccine patient had developed similar event in past. Further information regarding concurrent condition during vaccination, laboratory investigations excluding alternative etiologies for the reported event are needed to fully assess this case. Based upon the reported information, the role of the suspect vaccine cannot be assessed.
Gullian [[name]] Syndrome, Partial paralysis, pain about 2-3 weeks after influenza vaccination patient received Plasmapheresis treatment.  2/5/07 Received medical records from hospital which reveal that patient experienced progressive weakness of her [[name]]s & tingling of the toes over a 4 week period along with weakness of the hands, bladder urgency & low back pain.  Admitted 12/18/2002-12/23/2002.  On exam she had [[name]] weakness & absent ankle jerk reflexes.   Tx w/plasmaphoresis x 4.  Improved & was d/c to home with f/u by neuro.   FINAL DX: Guillain [[name]] syndrome; hypothyroidism; HTN; & lumbago.
After the administration of ADACEL, the patient complained of dizziness & numbness that spread from her left arm (site of injection) to lower extremities. She was also lethargic with mumbled speech. Patient fully recovered after 2 days but her hospitalization was prolonged by 2 days.
Client's age was 7 years at time of immunization. Instead of receiving fifth dose of Dtap and fourth dose of IPV, client should have received Tdap and IPV in separate immunizations.  No adverse events, symptoms, signs, treatment, etc to report.
This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (rash started by the knees and genital area and rash spread out all over the body) and FURUNCLE (Boil spot showed up) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Tuberculosis (The patient was infected with Tuberculosis four years ago and was hospitalized.) in 2017.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (rash started by the knees and genital area and rash spread out all over the body) (seriousness criterion hospitalization) and FURUNCLE (Boil spot showed up) (seriousness criterion hospitalization). The patient was hospitalized on 25-Mar-2021 due to FURUNCLE. At the time of the report, RASH (rash started by the knees and genital area and rash spread out all over the body) and FURUNCLE (Boil spot showed up) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   After the second dose of the Moderna vaccine, the patient developed a rash between 23-Mar-2021 or 24-Mar-2021. The son is not sure what exact date the symptoms  had started. The rash started on the patient's knees, spread to his genital area and then all over his body. The patient was hospitalized later on (the reporter was not able to remember the date). On an unspecified date, the patient was sent their primary care and to their dermatologist for follow up. The dermatologist only recommended to wash with water, since the doctor suspected it was from the Moderna-COVID-19 vaccine. Caregiver reported the symptoms were getting worse due to boils had formed. Treatment provided wash with water, no additional treatment was provided.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Case number PHEH2015US020613 is an initial spontaneous report received from a nurse on 13 Oct 2015. This report refers to a 39 year old female patient. Medical history and concomitant medication were not reported. The patient was vaccinated with an expired dose of FLUVIRIN (batch number: 1412701) at a dose of 0.5 ml, intramuscularly on 08 Oct 2015. No adverse event was reported following this medication error.
I developed a hard lump at injection site approximately 5 days following injection. It lasted for approximately 5-7 days.   At this time, beginning on 12/26/21, I have begun to have extreme muscle aches in my  legs from toes up. Extreme sharp pain. It has traveled up to my left arm and elbow area at this time and into my left hand.
pt fell-out @ kindergarten (preschool)  ground;was taken to ER;MD checked pt BS-WNL;MD felt like it was nerves from graduation ceremonies;
Approximately 8 hours after the shot I started feeling the onset of chills. Had chills and a fever (over 100) for approximately 4 hours. Had trouble sleeping through the night, profusely sweating, headache. 24 hours after the shot, I no longer had a chill/fever but continued to have a headache, be extremely hot/sweating, experience brain fog for 1-2 more days. Symptoms lessened over time, but I was still weak and had brain fog 72 hours after my injection. Soreness in my arm lasted about 5 days.
Very intense pain, very sore. My arm has been hurting for 11 days. Rashes appeared on both feet and ankles 7 days later.
This spontaneous report has been received from a pharmacist referring to a 57 year old female patient. There were no drug reactions/allergies. Information about concurrent condition, medical history or concomitant therapy was not reported. On 21-FEB-2001 the patient was vaccinated with ZOSTAVAX (dose, frequency, route and lot# not reported) for prophylaxis. It was reported that on an unspecified date in February 2017 the patient's injection site was a larger area of redness and had a blister at the injection site. There was no lab diagnostics studies performed. The pharmacist reported that the patient continued with redness at the injection site and had applied an unspecified topical ointment to the area and BENADRYL. The causality was not reported. This is one of the several reports from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1703USA002680.